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Abstract
Background—Internet-based platforms are increasingly prominent interfaces for social and 
sexual networking among men who have sex with men (MSM).
Methods—MSM were recruited through venue-based sampling in 2008, 2011, and 2014 in 20 
US cities. We examined changes in internet use (IU) to meet men and in meeting the last partner 
online among MSM from 2008 to 2014 using Poisson regression with generalized estimating 
equations to calculate adjusted prevalence ratios (APRs). We also examined factors associated 
with increased frequency of IU using data from 2014. IU was categorized as never, infrequent use 
(<once a week), and frequent use (≥once a week).
Results—Frequent IU increased from 21% in 2008 to 44% in 2014 (APR = 1.39, 95% 
confidence interval: 1.36 to 1.42), and having met the last partner online increased from 19% in 
2008 to 32% in 2014 (APR = 1.30, 95% confidence interval: 1.26 to 1.34). Those who never used 
the internet had fewer partners (median of 2 in the past 12 months, interquartile range: 1–4) 
compared with infrequent (4, 2–7) and frequent users (5, 3–12). HIV testing in the past 12 months 
also increased with increasing IU (58%, 68%, and 71%, respectively, P < 0.0001). Among HIV-
positive participants, the percent HIV-positive awareness increased as IU increased (71%, 75%, 
and 79%, P < 0.005).
Conclusions—Both IU to meet men and meeting the last partner online increased since 2008. 
Although men who used the internet more frequently reported more partners in the past 12 
months, they were also more likely to report testing in the past 12 months and were more likely to 
be HIV-positive aware.
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BACKGROUND
Internet-based dating websites or applications (apps) are increasingly being used for social 
and sexual networking among gay, bisexual, and other men who have sex with men (referred 
to collectively as MSM). Before the widespread use of the internet, meeting friends and sex 
partners often occurred in person at venues such as bars, parties, and public cruising areas. 
As personal computers became available and social network software was developed in the 
1990s, methods for MSM to meet other men broadened to include the internet. Websites 
rapidly developed in the early 2000s to provide services to those who wanted to meet 
people, including sexual partners, over the internet.1 Norms quickly shifted too, as one study 
of MSM in the United Kingdom found that the proportion of men under 30 who reported 
meeting their first sexual partner over the internet increased 20-fold from less than 3% in 
1992 to 61% in 2002.2 Because internet speed and coverage has rapidly increased, what 
began as chat rooms tied to a computer with limited visual capabilities have developed into 
websites and apps that are on mobile phones and allow instant sharing of photographs and 
location.3 Today, the use of geospatial social networking and dating apps and websites is 
common among all segments of the population and around the world.3 Although dating apps 
and websites are used by many different subpopulations, Grov et al3 reported in 2013 that 
MSM accessed dating apps on average 22 times a week compared to heterosexuals who 
accessed dating apps on average 8 times a week. Apps link MSM around the globe—one of 
the most popular apps for MSM is available in 196 countries and reports over 1,000,000 
users per hour.4
The first reported cases of HIV in the United States in the early 1980s were among MSM,5 a 
group that continues to be disproportionately affected by HIV. Despite representing 
approximately 2% of the US population,6,7 MSM accounted for 70% of all new HIV 
diagnoses (including MSM who inject drugs) in 2014.8 An estimated 15% of MSM 
Nationwide have HIV, with 11% estimated to be already diagnosed.9 Prevalence is even 
higher in the 20 cities that are part of the Centers for Disease Control and Prevention’s 
(CDC) National HIV Behavioral Surveillance (NHBS). In 2014, 22% of participating MSM 
were found to be HIV positive.10 Other sexually transmitted infections (STI), such as 
syphilis, have also increased among MSM in the United States.8,11
There is substantial evidence linking use of the internet to meet men to risky sexual 
behavior, including condomless anal sex and higher number of sexual partners.12,13 In 
addition, men recruited online report more risk behavior and more partners than those 
recruited offline.14 Although some studies have failed to show an association between use of 
networking apps to meet sex partners and risk of chlamydia and gonorrhea infection,15,16 
others have found a higher prevalence of these infections among MSM who use networking 
apps compared with those who met partners exclusively through in-person methods.1 
Furthermore, the internet has played a key role in several outbreaks of STIs among MSM.13 
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The high usage of dating apps and websites among MSM, coupled with high HIV and STI 
rates among users, make these apps potentially effective and efficient ways to reach a high-
risk population with prevention and care messages, and serving as effective channels to 
recruit participants for public health programs and research. We sought to examine trends in 
the internet use (IU) to meet men among a large sample of MSM recruited offline in 20 large 
cities in the United States. We used data among MSM participating in NHBS to evaluate 
changes from 2008 to 2014 in using the internet to meet or socialize with men and in having 
met the last sex partner online. We also investigated the association between using the 
internet to meet men, and HIV-testing behavior and risk behavior in 2014.
METHODS
NHBS collects data among MSM every 3 years. All NHBS participants must be aged ≥18 
years, live in a participating MSA or city, and be able to complete a behavioral survey in 
English or Spanish. The cross-sectional data reported in this analysis are from MSM 
recruited for interviews and HIV testing through venue-based, time-space sampling in 
surveys in the 20 cities that participated in NHBS (cities included in this analysis are: 
Atlanta, GA; Baltimore, MD; Boston, MA; Chicago, IL; Dallas, TX; Denver, CO; Detroit, 
MI; Houston, TX; Nassau-Suffolk, NY; New Orleans, LA; Los Angeles, CA; Miami, FL; 
Newark, NJ; New York, NY; Philadelphia, PA; San Diego, CA; San Francisco, CA; and San 
Juan, PR; Seattle, WA; and Washington, DC) in 2008, 2011, and 2014. NHBS-venue-based, 
time-space sampling procedures have been previously published.17,18 In each city, a team of 
staff members familiar with the local community conducted formative research to establish a 
list of venues frequented by MSM. Venues on the list were categorized as bar, dance club, 
fitness club or gymnasium, Gay Pride event, park or beach, large dance party (eg, rave or 
circuit party), cafe or restaurant, retail business, sex establishment or sex environment, social 
organization, street location, or another venue type, such as an event hosted by the local 
house ball community.
Interviews were conducted by trained interviewers using a standardized questionnaire 
covering demographics, HIV-associated behavior, and the use of HIV prevention and testing 
services. HIV testing was performed by collecting blood or oral specimens for either rapid 
testing in the field or laboratory-based testing followed by laboratory confirmation. 
Participants received incentives for participating in the interview and the HIV test. The 
incentive format (cash or gift card) and amount varied by city based on formative assessment 
and local policy. A typical incentive included $25 for completing the interview and $25 for 
providing a specimen for HIV testing. NHBS activities were approved by local institutional 
review boards in each participating city and as nonengaged research by the CDC.
Measures
IU to meet men was assessed with the question: “In the past 12 months, how often have you 
used the internet to meet or socialize with gay men either for friendship or sex? This could 
include social networking websites (such as Facebook or MySpace), websites directed 
toward gay men (such as Manhunt or Gay.com), or dating websites, or the use of mobile 
social apps (such as Foursquare or Grindr).” The 2008 measure of IU was slightly different 
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and specified using the internet to look for sex partners. Response options were grouped as 
follows: frequent (once a week/more than once a week/daily), infrequent (less than once a 
month/once a month/more than once a month), and never. Place where participants met their 
last sex partner was assessed with the following question: “Where did you first meet this 
partner?” We grouped responses as having met the last sex partner on the internet versus all 
other responses. Discordant condomless anal sex was defined as condomless anal sex at last 
sex with a partner of different or unknown HIV status. During the interview, participants 
were asked questions to determine if they had previously tested positive for HIV. After the 
interview, each participant was offered HIV testing. A nonreactive rapid test was considered 
a definitive negative result; a reactive (preliminary positive) rapid test result was considered 
a definitive positive only when confirmed by supplemental laboratory testing (eg, western 
blot, immunofluorescence assay or nucleic acid amplification test). Participants with a 
confirmed positive HIV-test result who reported having previously tested positive for HIV 
were considered to be aware of their infection.
Analysis
Men who consented to and completed the survey and had a male sex partner in the past 12 
months were included in analyses. The main outcomes for the analyses were having met the 
last sex partner online and frequent IU to meet or socialize with gay men. To determine if 
these outcomes changed over time, we used Poisson models with generalized estimating 
equations clustered on recruitment event to calculate adjusted prevalence ratios (APRs) and 
95% confidence intervals (CIs). Year was included in the model as an ordinal variable. 
Individual interaction terms for each covariate by year were included in models to examine 
changes over time by subgroup. Each PR measures change in the outcome for a 3 year 
increase in interview year (ie, 2008–2011 or 2011–2014). Age, race, and income were 
included as covariates. Using data from 2014, we also investigated the association between 
HIV testing, awareness of HIV status and risk behaviors, using the Wilcoxon rank sum and 
chi-square tests.
RESULTS
The analysis sample was n = 8881 in 2008, n = 9253 in 2011, and n = 9636 in 2014. The 
race, age, education, and income composition were similar across years. A larger proportion 
of participants were HIV positive based on the NHBS test results in 2014 (20%) compared 
with 2011 (17%) and 2008 (17%) (Table 1).
Having Met the Last Sex Partner Online
Across years, white MSM and those with an annual income of $75,000 or more had higher 
reports of meeting the last sex partner online. Overall, having met the last sex partner online 
increased from 19% in 2008 to 24% in 2011 and 32% in 2014 (APR = 1.30, 95% CI: 1.26 to 
1.34). IU increased over time in all age, race, income, and HIV-status categories (Table 2).
Frequency of Internet Use to Meet Men
The percentage of men who reported never using the internet to meet men decreased over 
time from 62% in 2008 to 36% in 2011, and 31% in 2014. Across all years, white MSM 
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were more likely to report frequent IU compared with other races. The percent of men who 
reported frequent IU increased from 21% in 2008 to 42% in 2011 and 44% in 2014 (APR = 
1.39, 95% CI: 1.36 to 1.42) and increased in all age, race, income, and HIV-status 
categories. Significant increases were seen in all cities but one (Table 3).
Characteristics of MSM by Frequency of Internet Use
Median number of male sex partners in the past 12 months increased with increasing IU. In 
2014, those who never used the internet had a median of 2 partners [interquartile range 
(IQR): 1–4] compared with a median of 4 among infrequent internet users (IQR: 2–7) and 5 
among frequent users (IQR: 3–12) (P < 0.0001). The percentage reporting any condomless 
sex in the past 12 months increased with increasing IU (55%, 67%, and 70%, P < 0.001). 
HIV testing in the past 12 months also increased with increasing IU (58%, 68%, and 71%, 
respectively, P < 0.0001). HIV prevalence decreased with increasing IU (25%, 20%, and 
20%, P < 0.0001). Similarly, the percent of HIV-positive MSM who were aware of their 
status was higher among nonfrequent and frequent internet users (71%, 75%, and 79%, P < 
0.005) (Table 4).
DISCUSSION
In a sample of men recruited offline in gay venues in large cities in the United States, IU to 
meet men was very common; in 2014, two-third of men had used the internet to meet other 
men and one-third had met their last sex partner online. Both the percentage of MSM using 
the internet frequently to meet men and the percentage of men who met the last sex partner 
online have increased since 2008, illustrating how common IU for social and sexual 
connection has become among MSM. Data from 2014 showed that men who used the 
internet more frequently had higher number of partners and higher reports of condomless 
sex. However, frequent internet users also had higher testing rates and were less likely to be 
HIV positive but unaware of their status.
As others have done before, we documented sexual risk among MSM using the internet to 
meet men. A recent meta-analysis found that meeting sex partners online was associated 
with increased risk of condomless anal sex, group sex, serosorting, and strategic positioning.
13
 We have reported previously on an association between frequent IU and a higher 
occurrence of recent and acute HIV infection among MSM.19 Case control studies in the 
United Kingdom found that men who use the internet to meet sex partners had twice the 
odds of seroconverting to being HIV positive compared with those who did not use the 
internet.20 Furthermore, several studies have shown increased prevalence of chlamydia and 
gonorrhea among men who use the internet to meet sex partners.1 However, it is important to 
note that it is not clear if the association between IU and high-risk sex is because of the 
internet facilitating riskier sex or to riskier men using the internet to meet sex partners. The 
internet environment may accentuate risk taking and make it easier to meet partners for 
condomless sex by providing an anonymous interface to disclose sexual preferences.12 
However, the association could also be because of high-risk men being more likely to use 
the internet to meet sex partners, as suggested by research showing higher number of 
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partners21 and STIs1 among those who meet partners online versus those meeting partners 
offline only.
Our data and data from others also suggest that MSM who use the internet more frequently 
are taking steps to protect their health. We found a lower HIV prevalence among those using 
the internet, and HIV-positive MSM who used the internet to meet men were more likely to 
be aware of their status. Furthermore, we found higher HIV testing among those using the 
internet more frequently. The formation of online partnerships may include intensive 
communications including risk negotiations before an offline, in-person contact is made.12 
In contrast, typical offline venues such as bars and clubs may not be conducive to such 
negotiations. However, risk negotiations do not invariably result in higher levels of protected 
sex; the accuracy of self-reported status among prospective sex partners cannot be taken for 
granted, as it depends on when the last HIV test occurred and on the veracity of the reported 
status.22 A recent survey of website/app owners, users, and public health professionals found 
agreement about several ways that dating apps and websites could be used to promote public 
health, including: automated HIV and STI testing reminders, local STI testing directories, 
access to sexual-health experts, profile options to include safer sex preference, and other 
strategies.23 There is also evidence that many MSM across age and racial/ethnic groups are 
using the internet generally, and dating apps and websites specifically, to receive and obtain 
sexual-health information.24,25 Encouraging frequent HIV testing among HIV-negative 
MSM using the internet to meet men and disclosure of HIV status among HIV-positive 
MSM may reduce the likelihood of discordant condomless sex and the potential for HIV 
transmission. A recent meta-analyses of HIV testing among MSM recruited online suggests 
that HIV-testing frequency is suboptimal and there is room for improvement.26 The ability to 
target messages to specific populations, on specific apps or websites, or in specific 
geographic areas gives great power to public health practitioners to tailor messages for 
maximum impact.
The findings in this report are subject to limitations. NHBS data are from MSM who were 
recruited at venues in cities with high HIV burden. Thus, results may not be generalizable to 
all MSM. Recruiting men at venues may lead to an underestimate of IU, however, if venues 
such as bars are popular locations to meet partners found online, it could lead to an 
overestimate of IU. Furthermore, analyses were based on self-reported data and may be 
subject to social desirability bias. In addition, all data are cross-sectional, thus we are not 
able to causally link use of the internet to meet men with risk or protective behaviors. The 
question to assess frequency of IU changed from 2008 to 2011, when most of the change 
was seen for increases in frequent use. However, these changes were accompanied by 
increases in having met the last sex partner online, a measure that remains unchanged. This 
provides evidence that the observed trends are real and not a measurement artifact. NHBS 
does not collect data on specific websites or apps used. There are likely important 
differences between using the internet for socializing and specifically to find sex partners 
that our study cannot investigate. Finally, data are not weighted to account for the complex 
sampling methodology used to recruit MSM. Point estimates may therefore be biased by 
over- or under-represented subgroups of the population. However, multivariate analysis of 
differences across years should not be affected by a lack of weighting, especially given the 
consistency of data distribution across years.
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Gay, bisexual, and other MSM represent two-thirds of new HIV diagnoses in the United 
States and are increasingly using the internet to meet men. It is encouraging to see more 
testing and high awareness of status among those using the internet frequently, but our data 
underscore the need for innovative and effective strategies to best HIV-prevention needs of 
MSM who use dating apps and websites. The implications of these trends for HIV or STI 
transmission risk are complex and suggest the need to develop online prevention strategies to 
reach MSM who use apps, who engaged in more condomless sex, and prevention strategies 
for men not using apps, who were less likely to be aware of their HIV status.
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